Real, lasting health isnt something you unlock by hitting a certain number on the scale
Researchers studying similar compounds have documented the importance of nutritional support alongside GLP-1 agonist protocols
And a growing body of evidence indicates that many of semaglutides anti-inflammatory and anti-fibrosis actions are independent of blood sugar improvements and weight-loss [1,3], greatly expanding the potential to help non-obese people who have a chronic condition
Some plans cover the medication for patients with BMI 30 or BMI 27 with weight-related comorbidities, but prior authorization requirements, step therapy protocols, and high copayments create significant barriers
Collectively, these factors increase sourcing risk, reduce supply reliability, and put upward pressure on costs for brands and distributors that depend on South American exports